Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 7758-87-4
2. Tricalcium Phosphate
3. Synthos
4. Calcium Phosphate Tribasic
5. Calcium Orthophosphate
6. Tricalcium Diphosphate
7. Calcigenol Simple
8. Beta-tcp
9. Tricalcium Orthophosphate
10. Beta-tricalcium Phosphate
11. Calcium Tertiary Phosphate
12. Tertiary Calcium Phosphate
13. Phosphoric Acid, Calcium Salt (2:3)
14. Fema No. 3081
15. Calcium Phosphate (3:2)
16. Tri-calcium Phosphate
17. Tricalcium;diphosphate
18. 10103-46-5
19. Calciresorb;tcp
20. Phosphoric Acid, Calcium Salt
21. Tricalcium Bis(phosphate)
22. Alpha-tricalcium Phosphate
23. Ins No.341(iii)
24. Chebi:9679
25. Ins-341(iii)
26. E-341(iii)
27. K4c08xp666
28. Synthograft
29. Bonarka
30. Cerasorb
31. Osferion
32. Natural Whitlockite
33. Caswell No. 148
34. Ceredex
35. Multifos
36. Ostram
37. Vitoss
38. Calciumphosphate
39. Tricos
40. Calipharm T
41. Tricafos P
42. 21063-37-6
43. Tricalcium Bis(orthophosphate)
44. Ccris 3668
45. Hsdb 879
46. Jax Tcp
47. Calcium Phosphate (ca3(po4)2)
48. Calcium Orthophosphate, Tri-(tert)
49. Tricalcium Phosphate (ca3(po4)2)
50. Einecs 231-840-8
51. Einecs 233-283-6
52. Unii-97z1wi3ndx
53. Epa Pesticide Chemical Code 076401
54. Posture (calcium Supplement)
55. Bone Phosphate
56. Phosphoric Acid Calcium(2+) Salt (2:3)
57. Unii-k4c08xp666
58. Ca3(po4)2
59. Calcium-phosphate
60. Alpha-tcp
61. Calcium Phosphates
62. Tricalciumphosphate
63. Posture (tn)
64. Hydroxyapatite Powder
65. Mfcd00015984
66. Calcigenol
67. Calcium Phosphate Basic
68. Beta Tricalcium Phosphate
69. Ai3-25607
70. Ec 231-840-8
71. 97z1wi3ndx
72. Chembl2106566
73. Dtxsid1049803
74. Calcium Phosphate [who-dd]
75. Tricalcium Phosphate [fhfi]
76. Tricalcium Phosphate [inci]
77. Precipitated Calcium Phosphate
78. Akos015833108
79. Phosphoric Acid, Calcium Salt (1:?)
80. Cx-0072
81. Db11348
82. Calcium Phosphate, Tribasic [mi]
83. Tricalcium Bis(orthophosphate), With A Fluorine Content Of Less Than 0,005 % By Weight On The Dry Anhydrous Product
84. Calcium Phosphate, Tribasic (ca.37% Ca)
85. Calcium Phosphate, Tribasic [hsdb]
86. Calcium Phosphate,anhydrous [vandf]
87. C3736
88. Cs-0013475
89. Ft-0645103
90. C08136
91. D00938
92. Q278387
93. Calcium Phosphate, Reagent For Transient & Stable Dna Transfections
94. Beta-tri-calcium Phosphate, >=95% Beta-phase Basis (unsintered Powder)
95. Calcium Phosphate, Purum P.a., >=96.0% (calc. As Ca3(po4)2, Kt)
96. Tricalcium Phosphate Hydrate, Nanopowder, <200 Nm Particle Size (bet)
97. Alpha-tri-calcium Phosphate, Puriss. P.a., >=75% Alpha-phase Basis (sinterted Powder)
98. Alpha-tri-calcium Phosphate, Reagent For Transient & Stable Dna Transfections
99. Beta-tri-calcium Phosphate, Puriss. P.a., >=95% Beta-phase Basis (sintered Powder)
100. Beta-tri-calcium Phosphate, Puriss. P.a., >=98% Beta-phase Basis (sintered Powder)
101. Beta-tri-calcium Phosphate, Puriss. P.a., >=98% Beta-phase Basis (unsintered Powder)
102. Calcium Phosphate (3:2) Mixture With Calcium Phosphate (1:1) [who-ip]
Molecular Weight | 310.18 g/mol |
---|---|
Molecular Formula | Ca3O8P2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 0 |
Exact Mass | 309.7946135 g/mol |
Monoisotopic Mass | 309.7946135 g/mol |
Topological Polar Surface Area | 173 Ų |
Heavy Atom Count | 13 |
Formal Charge | 0 |
Complexity | 36.8 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 5 |
... CHIEFLY USED AS GASTRIC ANTACID ... VALUABLE SOURCE OF CALCIUM ION, ESPECIALLY WHEN IT IS DESIRED TO SUPPLY BOTH CALCIUM & PHOSPHORUS. /FORMER USE/
Gilman, A. G., L. S. Goodman, and A. Gilman. (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 6th ed. New York: Macmillan Publishing Co., Inc. 1980., p. 1528
... /THIS/ ORALLY ADMIN CALCIUM ... /SALT/ CAN BE USED IN TREATMENT OF MILD & LATENT HYPOCALCEMIC TETANY & FOR MAINTENANCE THERAPY ... .
American Medical Association, Council on Drugs. AMA Drug Evaluations. 2nd ed. Acton, Mass.: Publishing Sciences Group, Inc., 1973., p. 202
AN EXCELLENT SOURCE OF BOTH CALCIUM AND PHOSPHORUS USEFUL IN SUPPLEMENTING CALCIUM INTAKE, AS, FOR EXAMPLE, DURING PREGNANCY & LACTATION, OR AS SOURCE OF CALCIUM IN DISEASES OF CALCIUM DEFICIENCY.
Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 770
Calcium replenisher
Budavari, S. (ed.). The Merck Index - Encyclopedia of Chemicals, Drugs and Biologicals. Rahway, NJ: Merck and Co., Inc., 1989., p. 256
For more Therapeutic Uses (Complete) data for TRICALCIUM PHOSPHATE (6 total), please visit the HSDB record page.
... CONTRAINDICATED IN TREATMENT OF HYPOCALCEMIA WITH HYPERPHOSPHATEMIA, WHICH MAY OCCUR IN HYPOPARATHYROIDISM AND RENAL FAILURE.
American Medical Association, Council on Drugs. AMA Drug Evaluations. 2nd ed. Acton, Mass.: Publishing Sciences Group, Inc., 1973., p. 201
Ceramic implant materials, including tricalcium phosphate, are biocompatible and are currently being used to restore alveolar bone loss resulting from periodontal disease, endodontic infections, and residual alveolar ridge resorption. However, use of such a material in this case led to persistent infection and additional bone destruction. Thus, the use of a ceramic implant material to accelerate periapical bone repair is not recommended in areas where a chronic bacterial infection is present.
PMID:3457349 Barkhordar RA, Meyer JR; Oral Surg Oral Med Oral Pathol 61 (2): 201-6 (1986)
For use as an over the counter calcium and phosphate supplement, antacid, or a source of calcium and phosphate in toothpaste.
FDA Label
Calcium phosphate reacts with acid in the stomach to raise the pH. In toothpaste it provides a source of calcium and phosphate ions to support remineralization of the teeth. As a supplement it provides a source of calcium and phospate, both of which are important ions in bone homeostasis.
A - Alimentary tract and metabolism
A12 - Mineral supplements
A12A - Calcium
A12AA - Calcium
A12AA01 - Calcium phosphate
/Ortho/ phosphate is absorbed from, and to a limited extent secreted into, the gastrointestinal tract. Transport of phosphate from the gut lumen is an active, energy-dependent process that is modified by several factors. ... Vitamin D stimulates phosphate absorption, an effect reported to precede its action on calcium ion transport. In adults, about two thirds of the ingested phosphate is absorbed, and that which is absorbed is almost entirely excreted into the urine. In growing children, phosphate balance is positive. Concentrations of phosphate in plasma are higher in children than in adults. This "hyperphosphatemia" decreases the affinity of hemoglobin for oxygen and is hypothesized to explain the physiological "anemia" of childhood. /Phosphates/
Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 1524
A defect in phosphate metabolism occurs in a variety of diseases. ... Rickets ... Osteomalacia ... Primary or Secondary Hyperparathyroidism ... Chronic Renal Failure. /Phosphates/
Hardman, J.G., L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A.G. Goodman (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996., p. 1525
The phosphate ions in calcium phosphate likely react with hydrochloric acid in the stomach to neutralize the pH. In toothpaste and in systemic circulation, calcium phosphate provides a source of calcium and phosphate ions to support remineralization of the teeth and bone homeostasis respectively. The increase in plasma calcium reduces calcium flux from osteocyte activity by reducing the secretion of parathyroid hormone (PTH). Calcium does this by stimulating a G-protein coupled calcium receptor on the surface of parathyroid cells. The reduction in calcium flux increases the amount of calcium deposited in bone resulting in an increase in bone mineral density. The reduction in PTH secretion also reduces the amount of vitamin D metabolized to its active form, calcidiol. Since calcidiol increases the expression of calcium dependent ATPases and transient receptor potential cation channel subfamily V member 6 (TRPV6) both of which are involved in calcium uptake from the gut, a reduction in calcidiol results in less calcium absorption. Additionally, TRPV5, the channel responsible for calcium reabsorption in the kidney, is downregulated when PTH secretion is reduced thus increasing calcium excretion via the kidneys. Another hormone, calitonin, is likely involved in the reduction of bone resorption during periods of high plasma calcium.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Taste Masking
Dosage Form : Tablet
Grade : Oral (Pharma Grade)
Category : Direct Compression, Fillers, Diluents & Binders, Film Formers & Plasticizers
Application : Direct Compression, Fillers, Diluents & Binders, Film Formers & Plasticizers
Excipient Details : KoVidone® VA64 is used as a binder in tablets, direct compression binder, matrix formers in amorphous solid dispersions, and film-forming polymer.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone and Vinyl Acetate Copolymer
Grade : Oral
Category : Direct Compression, Disintegrants & Superdisintegrants, Lubricants & Glidants
Grade : Oral
Category : Co-Processed Excipients, Controlled & Modified Release, Direct Compression
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Taste Masking
Dosage Form : Tablet
Grade : Oral (Pharma Grade)
Category : Direct Compression, Fillers, Diluents & Binders, Film Formers & Plasticizers
Brand Name : KoVidone® Ultra VA64
Application : Direct Compression, Fillers, Diluents & Binders, Film Formers & Plasticizers
Excipient Details : KoVidone® Ultra VA64 is used as a tablet binder, direct compression binder, matrix former in amorphous solid dispersions, and film-forming polymer.
Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP
Technical Specs : NA
Ingredient(s) : Polyvinylpyrrolidone and Vinyl Acetate Copolymer
Application : Direct Compression
Excipient Details : DC SIM 100 is a directly compressible simethicone powder used for antacid and anti-gas tablets.
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Grade : Oral
Category : Co-Processed Excipients, Direct Compression, Fillers, Diluents & Binders
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Chewable & Orodispersible Aids, Direct Compression, Fillers, Diluents & Binders, Taste Masking
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A TRIBASIC CALCIUM PHOSPHATE manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TRIBASIC CALCIUM PHOSPHATE, including repackagers and relabelers. The FDA regulates TRIBASIC CALCIUM PHOSPHATE manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TRIBASIC CALCIUM PHOSPHATE API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of TRIBASIC CALCIUM PHOSPHATE manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A TRIBASIC CALCIUM PHOSPHATE supplier is an individual or a company that provides TRIBASIC CALCIUM PHOSPHATE active pharmaceutical ingredient (API) or TRIBASIC CALCIUM PHOSPHATE finished formulations upon request. The TRIBASIC CALCIUM PHOSPHATE suppliers may include TRIBASIC CALCIUM PHOSPHATE API manufacturers, exporters, distributors and traders.
click here to find a list of TRIBASIC CALCIUM PHOSPHATE suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A TRIBASIC CALCIUM PHOSPHATE DMF (Drug Master File) is a document detailing the whole manufacturing process of TRIBASIC CALCIUM PHOSPHATE active pharmaceutical ingredient (API) in detail. Different forms of TRIBASIC CALCIUM PHOSPHATE DMFs exist exist since differing nations have different regulations, such as TRIBASIC CALCIUM PHOSPHATE USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A TRIBASIC CALCIUM PHOSPHATE DMF submitted to regulatory agencies in the US is known as a USDMF. TRIBASIC CALCIUM PHOSPHATE USDMF includes data on TRIBASIC CALCIUM PHOSPHATE's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The TRIBASIC CALCIUM PHOSPHATE USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of TRIBASIC CALCIUM PHOSPHATE suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing TRIBASIC CALCIUM PHOSPHATE as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for TRIBASIC CALCIUM PHOSPHATE API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture TRIBASIC CALCIUM PHOSPHATE as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain TRIBASIC CALCIUM PHOSPHATE and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a TRIBASIC CALCIUM PHOSPHATE NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of TRIBASIC CALCIUM PHOSPHATE suppliers with NDC on PharmaCompass.
TRIBASIC CALCIUM PHOSPHATE Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TRIBASIC CALCIUM PHOSPHATE GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TRIBASIC CALCIUM PHOSPHATE GMP manufacturer or TRIBASIC CALCIUM PHOSPHATE GMP API supplier for your needs.
A TRIBASIC CALCIUM PHOSPHATE CoA (Certificate of Analysis) is a formal document that attests to TRIBASIC CALCIUM PHOSPHATE's compliance with TRIBASIC CALCIUM PHOSPHATE specifications and serves as a tool for batch-level quality control.
TRIBASIC CALCIUM PHOSPHATE CoA mostly includes findings from lab analyses of a specific batch. For each TRIBASIC CALCIUM PHOSPHATE CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TRIBASIC CALCIUM PHOSPHATE may be tested according to a variety of international standards, such as European Pharmacopoeia (TRIBASIC CALCIUM PHOSPHATE EP), TRIBASIC CALCIUM PHOSPHATE JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TRIBASIC CALCIUM PHOSPHATE USP).
LOOKING FOR A SUPPLIER?